Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,475.00
-5.00 (-0.14%)
Aug 20, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 213.85 billion as of August 20, 2026. Its market cap has decreased by -40.55% in one year.
Market Cap
213.85B
Enterprise Value
268.62B
Revenue
94.42B
Ranking
n/a
PE Ratio
25.00
Stock Price
3,475.00
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 213.85B, a decrease of -52.62%. That is a compound annual growth rate of -14.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 213.85B | -30.91% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| i-SENS | 530.84B |
| WON TECH | 475.67B |
| Curexo | 398.98B |
| ToolGen | 348.56B |
| Value Added Technology | 309.71B |
| T&R Biofab | 122.74B |
| DRTECH | 96.42B |
| Osang Healthcare Co.,Ltd | 95.26B |